https://www.selleckchem.com/pr....oducts/hygromycin-b.
The latter was the only study to report outcomes for non-fatal CVEs and observed NAFLD to be an independent risk factor for this (propensity-matched HR=2.00, p=0.02). Two studies examined CKD progression; in one adjusted rate of percentage decline in estimated glomerular filtration rate per year was found to be increased in those with NAFLD (p=0.002), whereas the other found no significant difference. Few studies have examined the influence of NAFLD on prognosis and major adverse clinical outcomes within the CKD population. The stu
Me gusta
Comentario
Compartir
